Idiopathic Pulmonary Fibrosis- Current Status

Overview

"Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive lung disease characterized by scarring (fibrosis) in the lungs, which leads to reduced lung function and difficulty breathing. Current management focuses on slowing disease progression with antifibrotic medications, such as nintedanib and pirfenidone, and providing supportive care like oxygen therapy. Join us in this session to learn more.